drugset / Trial / NCT00443534
A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
NaSingle-groupOpen-labelTreatment
Summary
This protocol allows subjects who have participated in a previous SU011248 protocol the ability to continue to receive SU011248 after their study has ended.
Timeline
- Start
- 2006-05
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sunitinib | Small molecule | 25 mg | Oral |
| Subject | Sunitinib | Small molecule | 50 mg | Oral |